<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Rheumatology</title>
            <link>https://medicalxpress.com/rheumatology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Rheumatology</description>

                            <item>
                    <title>GLP-1 in joint fluid may let weight-loss drugs target arthritis directly</title>
                    <description>Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, stiffness, and a reduced quality of life. Treatment today focuses on reducing inflammation and relieving symptoms, depending on the type of arthritis. However, researchers from the Department of Biomedicine at Aarhus University have now identified a new possible route for future treatments. Their research is published in The Lancet Rheumatology journal.</description>
                    <link>https://medicalxpress.com/news/2026-04-glp-joint-fluid-weight-loss.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 16:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695569381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/arthritis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>PEPITEM &#039;replacement therapy&#039; shows potential for early-stage inflammatory arthritis</title>
                    <description>Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause joint damage.</description>
                    <link>https://medicalxpress.com/news/2026-04-pepitem-therapy-potential-early-stage.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 04:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news695035561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/wrist-pain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Nerve growth factor alone triggers osteoarthritis-like joint changes in healthy mice</title>
                    <description>Nerve growth factor (NGF) is a specialized protein, also called a neurotrophin, that is critical for the development and survival of nerves responsible for our senses and the body&#039;s fight-or-flight response. While the presence of NGF is crucial during the embryonic stage, its presence in adults is often an indication of inflammation, as it is a key mediator of pain for conditions like osteoarthritis (OA). Now, a study published in Arthritis &amp; Rheumatology shows that NGF is much more than a pain messenger—it can actually change the structure of a joint.</description>
                    <link>https://medicalxpress.com/news/2026-04-nerve-growth-factor-triggers-osteoarthritis.html</link>
                    <category></category>
                    <pubDate>Sun, 12 Apr 2026 11:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news694867180</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/nerve-growth-factor-al.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How an overactive immune system can drive cancer</title>
                    <description>The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system instead attacks the body&#039;s own cells. Conditions such as systemic lupus erythematosus (lupus) and rheumatoid arthritis are well-known examples. It is estimated that just under 250,000 people in Norway live with some form of autoimmune disease, with approximately 8% to 10% of the population worldwide.</description>
                    <link>https://medicalxpress.com/news/2026-04-overactive-immune-cancer.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 13:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news694958762</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-an-overactive-immu-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>CAR-T therapy drives remission in patient with three autoimmune diseases</title>
                    <description>For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment. The patient, who once required daily blood infusions, has been in remission without needing additional treatment for a year since the CAR-T therapy. The case report, published in Med, suggests that CAR-T therapies can help treat complex and severe autoimmune diseases.</description>
                    <link>https://medicalxpress.com/news/2026-04-car-therapy-remission-patient-autoimmune.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 11:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news694881961</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/car-t-therapy-drives-r.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists test new ways to regrow joints damaged by arthritis</title>
                    <description>Good news: Scientists may be closer to a new way to treat arthritis.</description>
                    <link>https://medicalxpress.com/news/2026-04-scientists-ways-regrow-joints-arthritis.html</link>
                    <category></category>
                    <pubDate>Tue, 07 Apr 2026 16:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news694783635</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-test-new-wa.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists pinpoint a skin alarm system pathway that links local damage to systemic immune responses</title>
                    <description>Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly monitoring for potential threats. In the skin&#039;s outermost layer, the epidermis, reside keratinocytes, cells that detect danger and actively orchestrate the body&#039;s immune response. How these cells perform this task in a localized manner and then communicate the message with the entire immune system had been a mystery, but now a team of researchers from China has uncovered the signaling pathway.</description>
                    <link>https://medicalxpress.com/news/2026-03-scientists-skin-alarm-pathway-links.html</link>
                    <category></category>
                    <pubDate>Mon, 23 Mar 2026 10:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news693479936</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-pinpoint-a-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>An immune signaling pathway drives pain in arthritis, researchers discover</title>
                    <description>Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the immune system to mistakenly attack body tissues, particularly joints, leading to inflammation, swelling, stiffness and pain.</description>
                    <link>https://medicalxpress.com/news/2026-03-immune-pathway-pain-arthritis.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 13:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news693227000</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-newly-discovered-sig.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Botox: A new therapeutic approach to treating finger ulcers and gangrene</title>
                    <description>Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as acute digital ischemia (which makes the fingers very painful, cold and sometimes white or bluish), digital ulcers (open wounds that heal poorly), and gangrene, according to a study recently published in JAMA Dermatology.</description>
                    <link>https://medicalxpress.com/news/2026-03-botox-therapeutic-approach-finger-ulcers.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 11:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news693221281</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/hand.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Key protein found to protect cartilage, offering new hope for osteoarthritis treatment</title>
                    <description>Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations. The disease is characterized by the gradual breakdown of cartilage, which normally cushions the bones within joints.</description>
                    <link>https://medicalxpress.com/news/2026-03-key-protein-cartilage-osteoarthritis-treatment.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 10:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news693221162</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/shp-protein-found-to-p.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Approved IV drug reduces lupus symptoms, clinical trial finds</title>
                    <description>An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers report in The New England Journal of Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-03-iv-drug-lupus-symptoms-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Mar 2026 17:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news692354707</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/approved-iv-drug-reduc.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeted PET/CT predicts early treatment response in rheumatoid arthritis patients</title>
                    <description>A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine. Compared to the three to six months currently required to establish treatment efficacy, this new imaging technique could help determine the patients who are most likely to respond sooner, allowing non-responders to pursue more effective therapies.</description>
                    <link>https://medicalxpress.com/news/2026-03-petct-early-treatment-response-rheumatoid.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Mar 2026 12:40:01 EST</pubDate>
                    <guid isPermaLink="false">news691676821</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/targeted-petct-predict.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Dry eye often precedes autoimmune disease diagnosis, new study finds</title>
                    <description>Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This symptom has long been associated with Sjögren&#039;s Disease, a chronic autoimmune condition in which the immune system mistakenly attacks the tear ducts and salivary glands, causing inflammation that leads to dry eyes and dry mouth. Now, a study of 67,264  patients in Taiwan with autoimmune diseases found that dry eye disease (DED) preceded the autoimmune diagnosis by about three years.</description>
                    <link>https://medicalxpress.com/news/2026-02-dry-eye-autoimmune-disease-diagnosis.html</link>
                    <category></category>
                    <pubDate>Wed, 25 Feb 2026 11:20:04 EST</pubDate>
                    <guid isPermaLink="false">news691236263</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/dry-eye-often-precedes.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Is exercise overrated for osteoarthritis? What the latest evidence suggests</title>
                    <description>The effectiveness of exercise therapy to ease the symptoms of osteoarthritis is likely minimal, short lived, and probably no better than no treatment at all, suggests an overarching (umbrella) systematic review and pooled data analysis of the available evidence, published in the open access journal RMD Open.</description>
                    <link>https://medicalxpress.com/news/2026-02-overrated-osteoarthritis-latest-evidence.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Feb 2026 18:30:06 EST</pubDate>
                    <guid isPermaLink="false">news690484201</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/treadmill-walk.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tiny one- to three-base RNAs could help stop autoimmune inflammation, study suggests</title>
                    <description>RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier&#039;s latest research, published in Nature Immunology, builds on the Nobel prize–winning discoveries of microRNA (2024) and siRNAs (2006), except where those molecules contain about 20 bases, these very short RNA fragments can be as small as 1–3 bases.</description>
                    <link>https://medicalxpress.com/news/2026-02-tiny-base-rnas-autoimmune-inflammation.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Feb 2026 15:00:06 EST</pubDate>
                    <guid isPermaLink="false">news689953649</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tiny-rna-holds-key-to-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>In comparing real-world costs and benefits of fibromyalgia medications, a clear winner emerges</title>
                    <description>Fibromyalgia is a long-term chronic condition that causes widespread pain in the muscles and soft tissues throughout the body. The illness can affect people of all ages and has a major impact on quality of life, often making even simple, everyday activities difficult. With an estimated 2–8% of the global population affected, the search for treatments that are both effective and affordable could be a game changer for how symptoms are managed for millions of people who live with the condition.</description>
                    <link>https://medicalxpress.com/news/2026-02-real-world-benefits-fibromyalgia-medications.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Feb 2026 11:00:06 EST</pubDate>
                    <guid isPermaLink="false">news689943345</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-study-compares-rea.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>B cells join T cells to drive sight-threatening arthritis in children</title>
                    <description>A team led by UCL researchers with Great Ormond Street Hospital (GOSH) and Moorfields Eye Hospital, found B cells—alongside T cells—play a key role in arthritis-related eye disease (JIA uveitis), a condition that can cause long-term vision loss in children. The study challenges how the disease has been previously understood, and could open the door to new treatments that help protect children&#039;s sight.</description>
                    <link>https://medicalxpress.com/news/2026-02-cells-sight-threatening-arthritis-children.html</link>
                    <category></category>
                    <pubDate>Wed, 04 Feb 2026 12:25:24 EST</pubDate>
                    <guid isPermaLink="false">news689430301</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/child-eye.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Alternate path for inflammation could improve rheumatoid arthritis treatment</title>
                    <description>The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don&#039;t work for up to 4 of every 10 patients.</description>
                    <link>https://medicalxpress.com/news/2026-01-alternate-path-inflammation-rheumatoid-arthritis.html</link>
                    <category></category>
                    <pubDate>Fri, 30 Jan 2026 11:00:22 EST</pubDate>
                    <guid isPermaLink="false">news688993201</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/arthritis.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
